BioForce Nanosciences Holdings Inc. (OTCMKTS:BFNH – Get Free Report) saw a large increase in short interest in the month of July. As of July 31st, there was short interest totaling 1,000 shares, an increase of ∞ from the July 15th total of 0 shares. Approximately 0.0% of the shares of the company are sold short. Based on an average daily volume of 7,702 shares, the days-to-cover ratio is presently 0.1 days.
BioForce Nanosciences Stock Performance
Shares of OTCMKTS:BFNH opened at $3.40 on Friday. BioForce Nanosciences has a 52-week low of $0.18 and a 52-week high of $3.40. The company has a market capitalization of $114.07 million, a P/E ratio of 340.34 and a beta of -0.52. The company has a 50-day simple moving average of $1.72 and a 200 day simple moving average of $1.00.
BioForce Nanosciences (OTCMKTS:BFNH – Get Free Report) last posted its quarterly earnings results on Monday, August 10th. The company reported $0.01 EPS for the quarter.
About BioForce Nanosciences
BioForce Nanosciences, Inc develops and markets precision instrumentation and proprietary technologies for the production and application of nanoscale materials. Its core platform employs nozzle-driven electrohydrodynamic processes to generate and deposit nanofibers, nanowires and nanoparticles with tight control over diameter, morphology and spatial arrangement. By tailoring electric field parameters and solution properties, the technology enables reproducible fabrication of structures at the nanometer scale.
The company’s product portfolio includes desktop electrospinning systems for nanofiber fabrication, electrospray modules for nanoparticle synthesis and integrated tools for bioprinting and surface patterning.
Featured Stories
- Five stocks we like better than BioForce Nanosciences
- AMG’s Alternatives Boom Powers Record Growth
- Microsoft’s Maia 300 Chip Targets NVIDIA’s AI Dominance
- 3 Unexpected ETFs Crushing the Market This Summer
- Is Best Buy the AI Winner Hiding in the Electronics Aisle?
Receive News & Ratings for BioForce Nanosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioForce Nanosciences and related companies with MarketBeat.com's FREE daily email newsletter.
